Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Aubagio TM
Active ingredients: teriflunomide
What it is used for
AUBAGIO is indicated for the treatment of patients with relapsing forms of Multiple Sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 30 degrees Celsius
- Store in Original Container
- Shelf lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
pale blue to pastel blue pentagonal film-coated tablets with '14' imprint on one side and engraved with a logo on the other
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient teriflunomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Medicines Australia Code of Conduct: breaches 201617 | Australian Prescriber
Australian Prescriber is a free, independent publication providing open access information about drugs and therapeutics.
Read more on Australian Prescriber website
Multiple sclerosis (MS) - myDr.com.au
Multiple sclerosis (MS) is a chronic, often disabling disease that attacks the central nervous system; new immunomodifying treatments have recently become available.
Read more on myDr website
Top results
Medicines Australia Code of Conduct: breaches 201617 | Australian Prescriber
Australian Prescriber is a free, independent publication providing open access information about drugs and therapeutics.
Read more on Australian Prescriber website
